middle.news
Amplia Therapeutics Surpasses $2.5M SPP Target, Fuelling Key Cancer Trials
11:19pm on Friday 29th of August, 2025 AEST
•
Healthcare
Read Story
Amplia Therapeutics Surpasses $2.5M SPP Target, Fuelling Key Cancer Trials
11:19pm on Friday 29th of August, 2025 AEST
Key Points
SPP raised A$2.65 million, surpassing original A$2.5 million target
Total capital raising including placements reaches A$27.65 million
Funds to support ACCENT and AMPLICITY clinical trials for narmafotinib
Plans to accelerate pivotal phase 2b/3 trial in second half of 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Amplia Therapeutics (ASX:ATX)
OPEN ARTICLE